新闻

  1. 主页
  2. 新闻
21 七月, 2020 12:00 上午

Navigating Regulatory Requirements for Drug Substances
7 七月, 2020 12:00 上午

Drug Substances – Managing Risks
14 六月, 2020 12:00 上午

The Future of Pharmaceutical Contract Development

Challenges in the EUGMP Inspection of Sterile Facility

11 五月, 2020 12:00 上午

Though there are man...

更多

Realignment in Drug Substances – POST COVID 19

23 四月, 2020 12:00 上午

PharmSol and its exp...

更多

A Perspective on Changing Regulatory Landscape in China Pharma Industry

8 四月, 2020 12:00 上午

With the structural ...

更多

PharmSol团队信息

13 二月, 2020 12:00 上午

在与新型冠状病毒肺炎(NCP)作斗争的关...

更多

PHARMSOL NEWS ISSUE NO. 5

28 十月, 2019 12:30 上午

Eugmp Qualification:...

更多